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Human platelets were prelabeled with [3H]inositol and exposed to thrombin or vasopressin. The radioactive 
inositol monophosphates were separated by high-performance liquid chromatography and identified by 
cochromatography with unlabeled standard substances. Radioactive inositol I-monophosphate (Ins 1-P) 
and inositol 4-monophosphate (Ins 4-P) were detected in unstimulated platelets and accumulated in re- 
sponse to thrombin or vasopressin. Ins 4-P as well as Ins 1-P increased after the formation of inositol 1,4- 
bisphosphate (Ins 1,4-P3 and inositol 1,4,5-trisphosphate (Ins 1,4,5-P& Lithium augmented the accumu- 
lation of Ins 1-P and Ins 1,4-P, in stimulated platelets, and also of Ins 4-P in platelets stimulated by vaso- 
pressin, but not by thrombin. The results indicate that Ins 1,4-P, formed in stimulated platelets is partly 
degraded to Ins 4-P. The significance of Ins 4-P as a marker molecule for the study of inositol phosphate 
metabolism in stimulated cells is discussed. 
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1. INTRODUCTION 
Ins 1,4,5-P3 and 1,2-diacylglycetol formed dur- 
ing receptor-activated breakdown of PtdIns 4,5-Pz 
may serve as second messengers for release of Ca2+ 
from intracellular stores and for protein 
phosphorylation [l-3]. As expected for an impor- 
tant second messenger, the enzymic formation and 
degradation of Ins 1,4,5-Ps might be tightly con- 
trolled. Recent enzymatic studies on rat liver have 
shown that a specific Ins 1,4,5-P3 S-phosphatase is
present in plasma membranes which degrades Ins 
1,4,5-Pj to Ins 1 ,4-PZ [4,5]. Unspecific phos- 
phatase activities present in the cytosol metabolise 
Abbreviations: Ins I-P, inositol I-monophosphate; 
Ins 2-P, inositol 2-monophosphate; Ins 4-P, inositol 
4-monophosphate; Ins 1 ,4-Pz, inositol 1 ,Cbisphos- 
phate; Ins 1,4,5-P3, inositol 1,4,.5_trisphosphate; Ptdlns, 
phosphatidylinositol; PtdIns 4-P, phosphatidylinositol 
4-monophosphate; PtdIns 4,5-P2, phosphatidylinositol 
4,5_bisphosphate; HPLC, high-performance liquid 
chromatography 
Ins 1,4-Pz further to Ins 1-P and Ins 4-P, respec- 
tively [4,5]. Besides a very recent study which 
describes small quantities of Ins 4-P in the brains 
of Li+-treated rats [6], only Ins 1-P has been found 
among the inositol monophosphates which in- 
crease following receptor activation of intact celIs 
or tissues (for references see [7]). Ins 1-P may, 
however, also derive from PtdIns hydrolysis by 
phospholipase C. 
We recently observed the formation of two 
[3H]inositol monophosphates in thrombin- 
activated platelets which cochromatographed on 
descending paper chromatography and on HPLC 
with Ins 1-P and Ins 2-P 181. By establishing an 
HPLC method which separates Ins l-P, Ins 2-P 
and Ins 4-P, this study describes that besides Ins 
1-P and trace amounts of Ins 2-P also Ins 4-P ac- 
cumulates considerably in activated platelets. 
2. MATERIALS AND METHODS 
2.1. materials 
LiChrosorbRNHz (5 pm) coIumns for HPLC 
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were obtained from Merck (Darmstadt). 
PBondapakNHl (30 x 0.39 cm) columns for 
HPLC were purchased from Waters Assoc. 
(Milford, MA). All other materials were obtained 
as described [8,9]. 
2.2. Measurement of tH]inositol phosphates in 
human platelets 
Platelet-rich plasma from 50 ml blood was cen- 
trifuged after addition of prostacyclin (300 ng/ml) 
and the platelets were resuspended in 1 ml of 
Tyrode-Hepes buffer containing 1 mM MgClz, 
1 mM EGTA, apyrase (100 pg), prostacyclin (2 pg) 
and 2 mCi [3H]inositol. The platelet suspension 
(2-2.5 x lo9 platelets per ml) was incubated at 
37°C for 4 h in a shaking water bath. Platelets 
were then pelleted by centrifugation at 800 x g and 
washed once in 8 ml Tyrode-Hepes buffer contain- 
ing inositol (5 mM), CaCl2 (0.1 mM), MgClz 
(1 mM), heparin (25 units/ml), apyrase 
(200 fig/ml), and prostacyclin (300 ng/ml). After 
centrifugation, platelets were resuspended in 
1.5-2 ml Tyrode-Hepes buffer containing CaClz 
(0.1 mM), MgCl2 (1 mM) and apyrase 
(200 ng/ml). The platelet concentration was ad- 
justed to l-l.3 x IO9 per ml. The platelet suspen- 
sion was kept at 37°C for 60 min to reach 
equilibrium between the free [3H]inositol and the 
[3H]inositol incorporated into platelet phospho- 
inositides. LiCl2 (10 mM final concentration) was 
added 60 min [lo] before addition of the platelet 
stimulus. 
Inositol monophosphates were separated from 
inositol bis- and trisphosphate by Dowex anion- 
exchange chromatography [8]. The dry platelet 
sample was dissolved in 3 ml H20, neutralised by 
addition of cyclohexylamine and applied to Dowex 
1 x 8 columns (1 ml, formate form). Fraction I 
(30 ml H20) was discarded; fraction II containing 
inositol monophosphates (30 ml of 200 mM am- 
monium formate, 100 mM formic acid) was passed 
through Dowex HCR-W2 columns to remove NH: 
[8]. The eluates were then dried at 40°C by 
rotoevaporation. The inositol monophosphates 
were further separated on new HPLC columns 
conditioned as described [9]. 
I used either a LichrosorbRNH2 (5 pm) or a 
pBondapakRNHz column. Separation was carried 
out utilizing a 20 min isocratic elution with 50 mM 
ammonium acetate/acetic acid buffer, pH 4.0 (sol- 
vent A), followed by a 60 min linear gradient to 
50% of solvent B (2 M ammonium acetate/acetic 
acid, pH 4.0) at a flow rate of 1 ml/min. Fractions 
were collected every 0.5 min and measured for 
radioactivity by liquid scintillation counting or for 
phosphorus [ 131. 
Samples of platelet suspension (1.0 ml) were 
placed into aggregometer tubes and platelets were 
stirred for 3 min before exposure to thrombin 
(2 U/ml) or vasopressin (1 PM). Aliquots (0.2 ml) 
were transferred at various times into 0.75 ml of 
chloroform/methanol/cone. HCl (100: 200: 2). 
After addition of a mixture of unlabeled Ins l-P, 
Ins 2-P, Ins 4-P, Ins 1,4-P2 and Ins 1,4,5-P3, the 
aqueous soluble inositol phosphates were extracted 
[91 and the samples were dried at room 
temperature under a stream of nitrogen. 
In experiments in which in addition radioactive 
Ins 1 ,4-PZ and Ins 1,4,5-P3 were measured, the dry 
platelet samples were dissolved in 200 yl solvent A 
and directly applied to HPLC [9]. Separation was 
carried out utilizing a 10 min isocratic elution with 
solvent A, followed by a 30 min linear gradient to 
25% solvent B, a 20 min linear gradient to 100% 
solvent B and a 20 min isocratic elution with sol- 
vent B at a flow rate of 1 ml/min. Fractions were 
collected every 1 min (from 1 to 25 min), every 
0.5 min (from 26 to 40 min) or every 2 min (from 
41 to 80 min), and measured for radioactivity or 
for phosphorus. 
3. RESULTS 
The preparation of Ins l-P, Ins 1,4-P2 and Ins An HPLC method was developed which 
1,4,5-P3 has been described [9]. Ins 4-P was also separates 3 inositol monophosphate isomers: Ins 
prepared by alkaline hydrolysis of phospho- I-P, Ins 2-P and Ins 4-P (fig.1). Both HPLC col- 
inositides [ 111. Phosphoinositides (100 mg) were umns tested (the LiChrosorbRNHz and the 
dissolved in 5 ml of 2 N KOH and refluxed for pBondapakRNH2 columns) could be used for the 
30 min. Inositol phosphates were then separated separation of the 3 inositol monophosphates. The 
by paper chromatography and eluted with water resolution of Ins 2-P and Ins 4-P decreased, 
[8,9,11,12]. The inositol monophosphate band 
contains mainly Ins 4-P, less Ins 1-P [l I] and also 
traces of Ins 2-P (see below). 
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Fig. 1. Separation of inositol monophosphate standards by HPLC. “C-labeled Ins I-P and Ins 2-P (W--O) produced 
by acidic hydrolysis of [*4C]PtdIns f9,14] were mi?ed with unlabeled Ins l-P, Ins 2-P and Ins 4-P (O---O) produced 
by alkaline hydrolysis of phosphoinositides [1 I] and applied to a LiChrosorbRNHz column. For details ee section 2. 
however, with longer use of the columns. It was 
observed that only HPLC could reliably resolve 
Ins 2-P from Ins 4-P. On descending paper 
chromatography, using as solvent either isopropyl 
alcohol/ammonia/water (70: 10 : 20) at 40°C [ 141 
or ethanol/l3.5 M NH3 (3 : 2) [ 151, and on silica 
gel glass fiber sheets [16] no separation of Ins 2-P 
from Ins 4-P could be achieved (unpublished). 
The method was applied to measure [3H]inositol 
monophosphates in human platelets which were 
prelabeled with [3H]inositol. Two major [‘Hlino- 
sitol monophosphate peaks on HPLC were found 
which cochromatographed exactly with unlabelled 
Ins 1-P and Ins 4-P, respectively. Both compounds 
were detected in small amounts in unstimulated 
platelets and accumulated following platelet ex- 
posure to thrombin (figs 2,3) or vasopressin (table 
1). In addition, a minor radioactive peak on HPLC 
was detected, which may correspond to Ins 2-P 
(fig.2). 
Thrombin (2 U/ml) as the stronger platelet 
stimulus induces a larger accumulation of inositol 
phosphates in human platelets than vasopressin 
(2 PM) (table 1). Interestingly, thrombin stimulates 
the accumulation of Ins 1-P more than that of Ins 
4-P. Vasopressin seems to increase Ins 1-P and Ins 
4-P to similar levels. 
Kinetic studies showed that Ins 1-P and Ins 4-P 
accumulate later than Ins 1,4-P2 and Ins 1,4,5-P3 
following platelet exposure to thrombin (fig.3) and 
vasopressin (unpublished). 
Li+ has a profound effect on the accumulation 
of inositol phosphates in human platelets. In 
unstimulated platelets, Li’ increased the levels of 
Ins 1-P and Ins 4-P but not of Ins 1,4-Pz. In 
platelets stimulated by thrombin, Li+ augmented 
the accumulation of Ins 1-P and Ins 1,4-P>, but not 
of Ins 4-P. Ins 4-P levels seemed to be even re- 
duced in the presence of Li+. In piatelets 
stimulated by vasopressin, Li+ augmented the ac- 
cumuIation of Ins I-P, Ins 4-P and Ins 1,4-Pz. Lit 
had no effect on the accumulation of Ins 1,4,5-PJ 
in resting or stimulated human platelets (fig.3, 
table 1). 
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Fig.2. HPLC separation of [3H]inositol monophosphates in control and thrombin-stimulated platelets. Human platelets 
prelabeled with [3H]inositol were exposed to saline or thrombin (2 U/ml) while stirring (1100 rpm) for 5 min at 37°C. 
The aqueous soluble [3H]inosito1 phosphates were extracted 191. unlabeled inositol monophosphate standards were 
added, and the inositol monophosphate fraction obtained by Dowex anion-exchange chromatography was further 
separated on HPLC. The fractions were measured for radioactivity of the platelet [3H]inositol phosphates (+-o) and 
for phosphorus (O---O) of the added inositol monophosphate standards. 
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4. DISCUSSION 
This study describes the presence of a [3H]ino- 
sitol monophosphate in human platelets which can 
be separated from Ins 1-P and Ins 2-P and 
- 
Fig.3. Time course of formation of [3H]inositol 
phosphates in thrombin-stimulated platelets in the 
presence (- - -) or absence (- ) of Li+. Human 
platelets prelabeled with [3H]inositol were kept at 37°C 
for 60 min in buffer with (open symbols, dashed line) or 
without (filled symbols, solid line) LiCl (10 mM). 
Platelets were then exposed to thrombin (2 U/ml) for 
various times. The aqueous soluble inositol phosphates 
were extracted, unlabeled inositol phosphate standards 
were added, and the inositol phosphates were separated 
by HPLC (see [9] and section 2). 
cochromatographs with Ins 4-P on HPLC. The 
cochromatography with an authentic standard 
gives evidence for the formation of [3H]Ins 4-P, 
but does not prove its structure. [3H]Ins 4-P is pre- 
sent in resting platelets and accumulates in 
platelets activated by thrombin or vasopressin. Ins 
4-P, similar to Ins 1-P increases after a time lag of 
lo-15 s and after the formation of Ins 1,4-PZ and 
Ins 1,4,5-P3 in platelets stimulated by thrombin 
(fig.3) or vasopressin (unpublished). 
Ins 4-P may serve as unique marker molecule for 
the study of inositol phosphate metabolism in 
stimulated cells. Among the inositol phosphates 
detected in stimulated human platelets [8- 10,171, 
Ins 4-P is the only compound which cannot be 
formed by phospholipase C-induced hydrolysis of 
phosphoinositides. Ins 4-P most probably derives 
from degradation of Ins 1,4-PZ by the action of 
non-specific soluble phosphatases [4]. Ins 1 ,4-PZ is 
Table 1 
Effect of Li+ on the accumulation of inositol phosphates in human platelets induced 
by thrombin or vasopressin 
Addition LiCl ‘H radioactivity (cpm) 
(10 mM) 
Ins 1-P Ins 4-P Ins 1,4-P2 Ins 1.4.5P1 
None _ 473 564 264 22 
+ 3390 2427 282 10 
Thrombin (4 U/ml) _ 11560 6824 3564 521 
+ 24080 5799 14480 584 
Vasopressin (2 PM) _ 1272 1384 596 160 
+ 11886 7095 2510 204 
Platelets prelabeled with [3H]inositol were incubated for 60 min at 37°C with or 
without 10 mM LiCl. Stimuli were added for 4 min. Inositol phosphates were 
separated by HPLC (see section 2) 
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formed either by phospholipase C-induced 
breakdown of PtdIns 4-P or from Ins 1,4,5-P3 by 
the action of a specific Ins 1,4,5-PX 5phosphatase 
[4,5,8,18]. According to the latter pathway Ins 4-P 
might ultimately derive from Ins 1,4,5-Ps. The 
presence of Ins 4-P in stimulated platelets indicates 
that the inositol monophosphates found in 
stimulated cells may not only derive from PtdIns 
hydrolysis but also from the stepwise degradation 
of inositol polyphosphates [4]. 
The observed effects of Li+ on the accumulation 
of inositol phosphates are in agreement with en- 
zymatic studies in rat liver [4,5,18] and with studies 
of thrombin-stimulated human platelets 1171 and 
muscarinic receptor activation in rat brain and 
parotid gland 119,201. They differ, however, 
sharply from results obtained in rabbit platelets 
[lo]. Here, Li+ augmented markedly the ac- 
cumulation of Ins 1 -P and Ins 1,4-P2 in stimulated 
platelets which is explained by the sensitivity of the 
responsible phosphatase activities to Li+ [4]. Ac- 
cumulation of Ins 4-P is augmented in vasopressin- 
but not in thrombin-stimulated platelets. Since 
vasopressin is a weaker platelet agonist and in- 
duces less accumulation of Ins 4-P than thrombin, 
it seems that the degradation of Ins 4-P is only in- 
hibited by Li+, if the Ins 4-P levels are low. The ac- 
cumulation of Ins 1,4,5-P3 in stimulated platelets 
was barely affected by Li” which corresponds to 
the insensitivity of the Ins 1,4,5-P3 5-phosphatase 
to Li+ [4,5,18]. The observation that Li+ induces 
an accumulation of Ins I-P and Ins 4-P in non- 
stimulated platelets may indicate that both inositol 
monophosphates are produced and degraded in 
resting platelets. Interestingly, Li+ does not induce 
an accumulation of Ins 1,4-P2 in resting platelets. 
The results reveal interesting differences in the 
action of thrombin and vasopressin on the ac- 
cumulation of inositol phosphates in human 
platelets. Thrombin induces a higher increase of 
Ins 1-P than of Ins 4-P whereas vasopressin 
stimulates Ins 1-P and Ins 4-P levels to a similar 
degree. Since according to enzymatic studies the 
phosphatase activities remove the I- and 
4-phosphate groups of Ins 1,4-PZ at similar rates, 
the similar levels of Ins 1-P and Ins 4-P in 
vasopressin-stimulated platelets could indicate that 
both compounds are formed entirely from Ins 
1,4-Pz. In contrast, the relatively higher accumula- 
tion of Ins I-P compared to Ins 4-P in thrombin- 
156 
activated platelets may lead to the conclusion that 
PtdIns is also hydrolysed. The results show that 
the detection and the determination of Ins 4-P 
gives further insights into the metabolism of ino- 
sitol phosphates and inositol phospholipids in 
stimulated cells. 
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